PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 67 filers reported holding PASSAGE BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $28 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $6,200,000 | 10.57% |
Lynx1 Capital Management LP | 2,752,422 | $3,441,000 | 3.10% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $1,545,000 | 2.89% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,122,000 | 1.85% |
Frazier Life Sciences Management, L.P. | 3,756,915 | $4,696,000 | 0.36% |
Orbimed Advisors | 8,931,999 | $11,165,000 | 0.21% |
Newtyn Management, LLC | 300,000 | $375,000 | 0.08% |
Deep Track Capital, LP | 1,439,062 | $1,799,000 | 0.08% |
Rubric Capital Management LP | 822,105 | $1,028,000 | 0.05% |
Oasis Management Co Ltd. | 240,000 | $300,000 | 0.05% |